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This Special Issue focuses on the significance of the expression of neural cell adhesion molecules in 
development and disease. These molecules may belong to different gene families and may be 
involved in distinct developmental events with Cadherins, Integrins, the Semaphorins and the 
Immunoglobulin Superfamily representing the main groups (Hayashi and Takeichi. 2015; Gardiner, 
2011; Battistini and Tamagnone, 2016; Irintchev and Schachner, 2012). This SI mostly focuses on 
components of last family (IGSF). Early studies demonstrated that expression of these molecules 
was critical both during development and in the adult nervous tissue and were  responsible for the 
ability of cultured neural cells to undergo an adhesive behaviour,  However, the advent of gene 
targeting technologies, particularly in mice, made it evident that many of these so-called adhesion 
molecules were rather endowed with complex developmental functions and that their adhesive 
properties should perhaps be regarded as an epiphenomenon of their functional make up. This led to 
the early definition of these cell surface glycoproteins as ‘morphoregulatory’ molecules (Edelman 
et al., 1992), reflecting that such proteins are specifically involved in the complex mechanisms 
modulating the shape of nervous tissues. Encompassed in this concept was the idea that rather than 
simply acting as glue, such molecules transmit transmembrane signals involved in developmental 
control and that, as such, they should be regarded as signalling molecules, whose ultimate role was 
to regulate neural morphology at cellular and tissue levels. A corollary of this assumption is that 
precise regulation of the genes encoding these molecules is a critical element of their developmental 
function and, therefore, that alteration in their expression profiles could result in neurological 
disorders. The different contributions of this Special Issue focus on different aspects of this general 
topic.  
 
The review article from Takeshi Sakurai deals in general with the significance of changes of CAM 
expression and function in neuropsychiatric disorders and provides a framework for thinking about 
the different levels at which alterations to circuitry may occur. Although mutations in CAMs are 
known to be causal in neurological disease, most notably in the L1CAM-associated MASA/CRASH 
syndromes, more typically rare genetic or copy number variants have been found associated, among 
others, with intellectual disability (ID), autism spectrum disorder (ASD) schizophrenia (SZ) and 
peripheral neuropathies. Focussing particularly on the fact that CAMs are often incorporated in 
multimeric complexes, in which changes in individual components may lead only to subtle changes 
in neuronal circuitry, the author contends that CAM genes are important ‘risk genes’ in 
neuropsychiatric disorders and suggests five ways in which such subtle changes may make the 
organism vulnerable to neurological disease. Most obviously this may result from the known 
importance of CAMs to the function of mature circuits, and he highlights roles in the trafficking of 
 3 
synaptic components which may affect homeostatic plasticity. However, this may also result from 
circuitry modification during development, arising from effects on early differentiation (neuronal 
specification/axonal growth/fasciculation), but also from later-activated mechanisms, such as target 
recognition, synapse formation and myelination, and involving diverse adhesion families, including 
cadherins, Ig superfamily and integrins, as well as members of the Semaphorin family.  
The assumption that changes in the expression of the morphoregulatory glycoproteins encoding 
genes may contribute to neurological disorders is consistent with the general idea that the activation 
profile of the underlying genes is a critical aspect of their function and that changes in their profile 
may be causative in specific pathologies of the nervous system.  
 
The review from Alexander Dityatev and Hristo Varbanov concerns one of the most widely 
characterized adhesion molecule of the nervous tissue: the Neural Cell Adhesion Molecule NCAM. 
Rather than focusing on its adhesive properties, the manuscript summarizes the relationship of 
NCAM with the functions of neural circuits, in particular with synaptic plasticity, through its 
activation of the N-methyl-D-aspartate-receptors (NMDARs), revealing distinct roles for the 
NCAM polypeptide and its polysialic acid modification in different circuits.  A role for the 
polysialylated form of the NCAM (PSA-NCAM) acting on extrasynaptic NMDAR is also 
discussed. This interaction is thought to inhibit the activation of extrasynaptic NMDAR which 
otherwise would inhibit LTP and activate cell death. Polysialylated NCAM interactions with the 
extrasynaptic form of the NMDAR thus results in positive effects on long term potentiation and 
counteracts neurodegeneration and in the hippocampus and medial prefrontal cortex promotes 
neurogenesis, and enhances synaptic plasticity and learning. Interestingly, much of this suppression 
appears to be mediated by soluble PSA-NCAM and the review explores the mechanisms leading to 
PSA-NCAM shedding from GABAergic interneurons, which indicates that this may involve Ephrin 
family components and activation of ADAM proteases.  
The authors also explore the association of alterations of PSA-NCAM expression with 
neuropsychiatric  disorders, notably with schizophrenia, bipolar disorder, depression anxiety and 
Alzhemier’s disease, and examine the potential of PSA as a therapeutic agent in such diseases. 
  
Andreas Faissner and colleagues focus on the interactions of adhesion molecules with 
extracellular matrix components which, together with other ECM-associated proteins, comprise the 
set of proteins encoded by the genes of the so-called matrisome. The authors are particularly 
concerned with the elucidation of the ECM interactome associated with the neural stem cell niche, 
most specifically with Tenascin C (Tnc), a component of the tenascin family, which is presented as 
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a model of ECM components specific to the nervous system. Its role in the modulation of 
proliferation and differentiation events of neural precursor cells, with particular reference to stem 
cells and their role in neural regeneration is discussed. Aside from being a ligand for integrins and 
contactins, Tnc is also known to bind cytokines and morphogens (TGFbeta1, wnt3a, PDGF, FGF2, 
NT3) and stimulate the EGF receptor via its EGF repeats. Perhaps not surprisingly then, it is highly 
expressed in malignant glial tumors and is upregulated in CNS lesions, all consistent with a critical 
role in regulating neural precursor behaviour.  
 
The remaining reviews of this Special Issue take a tour through three different families of CAMs of 
the immunoglobulin supergene family that each have striking expression in different aspects of 
neural development, from expression on early progenitors through clear roles in synaptogenesis and 
myelination, though the overall lesson is that trying to tie a specific molecule to a single stage of 
development is futile and instead nature efficiently reuses its tools again and again.  
 
Fritz Rathjen and colleagues deal with the Cosackievirus and Adenovirus Receptor (CAR)-like 
cell adhesion molecules family, a less well-studied  subfamily of the Ig superfamily, comprising 
CAR itself, CLMP (CAR-like membrane protein) and BT-IgSF (brain and testis specific 
immunoglobulin superfamily). Although widely expressed in a variety of tissues, these exhibit a 
striking profile in nervous tissues, CAR and CLMP being highly expressed in development but 
replaced by BT-IgSF, which shows the reciprocal pattern as maturation proceeds. CAR proteins are 
transmembrane proteins built by the association of a N-terminal V type domain with C-terminal C2 
domain, both involved in homotypic cell adhesion. These proteins are concentrated at specific sites 
of cell comminications, the gap and tight junctions. Although the only disorders associated with this 
family in humans so far relate to the association of gastrointestinal disease with mutations in CLMP 
mutation, CAR knockout mice exhibit behavioural changes that may be associated with impaired 
hippocampal neurogenesis, while BT-IgSF knockouts are disrupted in aspects of AMPAR-mediated 
synaptic transmission in the hippocampus. Since CAR levels appear reduced in the inflamed 
hippocampus of patients with late onset Alzheimer’s Disease, this may indicate a role for CAR 
proteins in neurodegenerative disorders. 
 
Esther Stoeckli turns to the so-called synaptic cell adhesion molecules (Syn CAMs). These are 
Immunoglobulin superfamily components which classically have the property of being able to 
induce synapse formation in non-neuronal cells and as such they may be considered as true synaptic 
cell adhesion molecules. However, as Stoeckli discusses, they also mediate axo-glial contacts 
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formation, indicating their involvement in myelination and, in addition, have recently been shown 
to have roles in axon guidance in both the central and peripheral nervous tissue, suggesting that 
SynCAMs may in fact, like many of the families discussed in this Special Issue, also be ‘Jacks of 
all trades’ in neurodevelopment.  Correspondingly, mutations in SynCAM genes are also identified 
as causal or risk factors in neurodevelopmental disorders, notably for intellectual disability and 
autism spectrum disorders, and knockout mice exhibit social and emotional behaviour deficits.  
 
The Contactin (Cntn) subset of the Immunoglobulin supergene family (IgC2/FNIII molecules) 
includes molecules which share structural properties (the association of Immunoglobulin type C2 
with Fibronectin type III domains), as well as a general role in cell contact formation and in axonal 
growth control. This subset includes 6 highly related components (Contactin 1 to Contactin 6) all of 
them associated with the cell membrane via a Glycosyl Phosphatidyl Inositol (GPI)-containing lipid 
tail. The highest similarity is shared by Contactin 1 and Contactin 2 (~50% at the protein level). 
These are cell surface components, which bind heterophilically to multiple partners including 
members of the related L1CAM and of the Neurexin family (Contactin-associated proteins  
CNTNAPs or CASPRs).  
Besides to the organisation of the neuronal membrane, these molecules also contribute to axonal 
growth and pathfinding control and promote axonal interactions with myelinating cells at the 
paranodal and juxtaparanodal regions, leading to differential ionic channels (both Na+ and K+) 
distribution, an event of critical relevance in the generation of the peak-shaped action potential.  
The Contactins also appear to have a role in degenerative and inflammatory disorders. Contactin 2 
is suggested to be involved in Alzheimer disease and is a known ligand of the Alzheimer Precursor 
Protein (APP), binding to which promotes release of Alzheimer Intracellular domain (AICD) and 
negatively modulates neurogenesis. Contactin-1 overexpression also has effects on neurogenesis, 
but appears to do so through activation of Notch signalling via the Hes pathway. Activation of 
Notch signalling may also be consistent with its ability to modulate neuroinflammation events, and 
with the possibility that Contactin 1-dependent interactions participate to the pathogenesis of neuro 
inflammatory disorders, incuding the Multiple Sclerosis.  
 
The contribution from Daniela Puzzo and colleagues extends the analysis of Contactin 1 function 
by exploring its role in hippocampal synaptic plasticity and in memory in both adult and aged mice, 
achieved by studying Long-Term Potentiation as well as spatial and recognition memory. They 
investigate the molecular pathways underlying these functions and demonstrate the involvement in 
such events of the CREB transcription factor phosphorylation. With potential significance for 
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neurological disorders, the molecule was also found to influence neuronal apoptosis, including the 
production of amyloid-beta peptide (Aβ), and therefore, as for Contactin 2, also Contactin 1 was 
proposed to be one of the pathogenetic hallmarks of Alzheimer's disease (AD). 
 
Finally, Peter Burbach and colleagues review recent genetic studies that implicate contactins 4, 5 
and 6 as candidate genes in neuropsychiatric disorders, particularly autism spectrum disorders, 
intellectual disability, schizophrenia, attention deficits iperactivity disorders, bipolar disorders, 
alcohol use disorders and Anorexia Nervosa. This is consistent with the studies on the 
developmental function of these proteins, which demonstrate roles in cell survival, neurite growth 
and pathfinding, and on subsequent circuit formation. These studies also indicate the existence of a 
differential code for Contactin expression within the different neural regions including the retina, 
the cerebral cortex and the thalamus, which in turn may differentially affect the developmental 
organization of these structures.  
Overall, it may be supposed that the modulation of the Contactin code is of central relevance in 
neural developmental control and that, in turn this may result in the definition of the binding 
specificity of the neuronal surface. However, besides trans-interactions with distinct ligands, this 
certainly involves cis-association of these GPI-anchored molecules with transmembrane partners, 
which in turn allows them to interact with the submembrane compartment. Therefore these different 
mechanisms based on both cis-association and trans-interactions of the so called cell adhesion 
molecules both contribute to build the complex molecular machine, which, while modulating the 
nervous tissue differentiation during physiological development may also mediate the neural 
damage in specific circumstances. 
 
Where now? 
Add to the molecular complexity detailed above, and in the Special Issue reviews, the overlying 
complexity and robustness of the circuits being built, and it becomes clear that simply knocking out 
or overexpressing genes and then looking either at the static anatomy of the resulting circuits, or the 
behaviours of the lab animals is only going to get us so far, particularly when environmental insults 
are major contributors to the triggering of neurological disease, as seems to be the case. What 
clearly is needed is the ability to observe the activity of circuits in the behaving living animal while 
protein functions are altered in real time. Despite advances in powerful genetics and in vivo 
imaging (e.g. http://www.nature.com/nmeth/journal/v12/n2/abs/nmeth.3217.html), achieving this 
goal in the mouse still appears to remain a long way off. Thus, while the mouse undoubtedly will 
remain the workhorse in this area, not least because of the wealth of experience with this model and 
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its relevance to humans, it may nonetheless be time for those studying the roles of CAMs in the 
formation and function of neural circuits to consider the usefulness of simpler more tractable 
systems, such as the zebrafish, where recent advances in genetics and imaging are now making this 
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